Profile
Christopher Kevil was the founder of TheraVasc, Inc. which was founded in 2008, where he held the title of Chief Scientific Officer from 2008 to 2016.
He also worked as Director-Vascular Biology & Angiogenesis at LSU Health System Health Care Services Division.
Dr. Kevil holds a doctorate degree from Louisiana State University and an undergraduate degree from Northwestern State University.
Former positions of Christopher Kevil
| Companies | Position | End |
|---|---|---|
TheraVasc, Inc.
 TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Founder | 2015-12-31 |
| LSU Health System Health Care Services Division | Corporate Officer/Principal | - |
Training of Christopher Kevil
| Louisiana State University | Doctorate Degree |
| Northwestern State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
TheraVasc, Inc.
TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
| LSU Health System Health Care Services Division |
- Stock Market
- Insiders
- Christopher Kevil
